# Lemborexant Treatment of Insomnia Linked to Epilepsy

> **NCT06262594** · PHASE3 · RECRUITING · sponsor: **University of Manitoba** · enrollment: 26 (estimated)

## Conditions studied

- Epilepsy
- Sleep

## Interventions

- **DRUG:** Lemborexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06262594
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-29
- **Primary completion:** 2026-04-18
- **Final completion:** 2027-04-18
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06262594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06262594, "Lemborexant Treatment of Insomnia Linked to Epilepsy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06262594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*